Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine.
<h4>Background</h4>E. coli belonging to the phylogenetic group B2 are linked to Inflammatory Bowel Disease (IBD). Studies have shown that antimicrobials have some effect in the treatment of IBD, and it has been demonstrated that E. coli Nissle has prophylactic abilities comparable to 5-a...
Guardado en:
Autores principales: | Andreas Munk Petersen, Susanne Schjørring, Sarah Choi Gerstrøm, Karen Angeliki Krogfelt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb826f19326249efaf3ef6b4bd740de6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Pichet Praveschotinunt, et al.
Publicado: (2019) -
Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine.
por: Rosalie Maltby, et al.
Publicado: (2013) -
E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
por: Theodore A. Chavkin, et al.
Publicado: (2021) -
E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis
por: Louis C Dacquay, et al.
Publicado: (2021) -
Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Teresa Pérez-Berezo, et al.
Publicado: (2017)